This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566054300 units of Ondansetron ODT 4 mg tablets. The $2,930.68 firm fixed-price contract has an ultimate completion date of October 9, 2024 and does not utilize any set-aside designation, indicating open competition.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that broader IDC agreement, enabling efficient government procurement of essential medications to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/27/25, 10:42 AM